The PRESS RA: Protein and Resistance Exercise Supplementation Study for Rheumatoid Arthritis (PRESSRA)
The PRESS RA Study: Protein and Resistance Exercise Supplementation Study for Rheumatoid Arthritis
Sponsor: American College of Rheumatology Research and Education Foundation
Terminated
Funding ended
Other Rheumatoid Arthritis trials with similar outcome
Listed as NCT02078375, this NA trial focuses on Rheumatoid Arthritis and remains terminated or withdrawn. Sponsored by American College of Rheumatology Research and Education Foundation, it has been updated 7 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
May 2019 — Jan 2021 [monthly]
Terminated NA
Status: Suspended → Terminated
-
Jun 2018 — May 2019 [monthly]
Suspended NA
▶ Show 2 earlier versions
-
Sep 2017 — Jun 2018 [monthly]
Suspended NA
Status: Recruiting → Suspended
-
Jan 2017 — Sep 2017 [monthly]
Recruiting NA
First recorded
Feb 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- American College of Rheumatology Research and Education Foundation
- Johns Hopkins University
- National Institute on Aging (NIA)
For direct contact, visit the study record on ClinicalTrials.gov .